Convaid today announced that it has been acquired by Etac AB for an undisclosed amount. Etac, a Sweden-based group, offers a wide range of solutions for mobility with manual wheelchairs, advanced seating solutions, solutions for patient transfer and vital solutions needed for everyday life including classic products for bathing and toilet. They also provide a world-class, state of the art range of solutions for pediatric use through the R82 brand.

Convaid was founded in 1976 by Merv and Rachel Watkins in California and three patents were filed. The first patented folding wheelchair was called the “Cruiser.” The name “Convaid” comes from “convalescent aids.” Since then the company has grown to become a leader in the high-performance, lightweight, easy-to-use and attractive mobility products market for all stages of a young person’s life, from infancy to young adulthood.

Convaid’s President Chris Braun said, “We are extremely pleased with this opportunity. Etac-R82 is known for its high quality, safety, design and vision to put the customer first. These are shared pillars of our companies’ cultures and we also share the mission of improving the lives of children with special needs and their families. This is a great fit for Convaid and Etac-R82, and together we will form a very strong platform in the world of pediatrics, not only in North America but in all global markets. We look forward to continuing to bring innovation, investment in R&D to expand our product portfolio, and improvements in customer experience and service as part of the Etac group.”

Etac’s President Torben Helbo said, “Convaid is a very well-known and respected brand, with strength in design, manufacturing and marketing pediatric products which fulfill a clear niche in the mobility market. Convaid brings leading technologies, market expertise and top quality products to Etac-R82, which will further strengthen our ability to meet the needs of the pediatric population.”

Convaid and Etac, with their R82 brand, combined will be one of the world-wide leaders in the pediatric special needs market.

Convaid’s product line of mobility products are typically prescribed for children with mild to moderate involvement concurrent to the following conditions:  Cerebral palsy, Down syndrome, Duchene Muscular Dystrophy, Spinal Muscular Atrophy, Spinal Bifida, Osteogenesis Imperfecta, Traumatic Brain Injury, Spinal Cord Injury, Cystic Fibrosis, Mitochondrial Disease, Metabolic Diseases, and Sensory Processing Disorders, among others.

About Convaid

Convaid, the company that invented the adaptive assisted wheelchair, has helped special needs children and their families live fuller, more productive lives since 1976. Convaid produces high-performance, easy-to-use and attractive mobility products for all stages of a young person’s life, from infancy to young adulthood. Each product is custom-built to individual specifications to provide optimum comfort, safety and convenience.

About Etac

For more than forty years, Etac has developed products and services, which create possibilities for users and caregivers. Today Etac offers a wide range of solutions for mobility with manual wheelchairs, advanced seating, patient transfer and bathing and toilet. Etac markets their products under the Etac, Molift, Immedia and R82 brands.

R82 was founded in 1982 and has since grown to be a truly global supplier of high quality aids for children and teenagers with special needs. With a range of products in seating, standing, walking, transportation, bath and toilet, R82 offers solutions for almost any situation in a disabled child’s life.

Etac-R82 operates sales companies in Sweden, Norway, Denmark, Germany, the Netherlands, the United Kingdom, Australia and the United States. Furthermore, Etac-R82 has an extensive network of distributors in 40 other markets around the world.

For further information, please contact:
Chris Braun
Torben Helbo
President, Convaid Products Inc. President and CEO Etac AB
Telephone: + 1 310-618-0111 Telephone: +46-8-633 47 00
Etac website
R82 website

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *